RP-6306

• Description:

  Lunresertib (RP-6306) is a potent, selective, and orally active PKMYT1 inhibitor with an IC50 of 14 nM. Lunresertib (RP-6306) inhibits the growth of CCNE1-amplified tumor cells in several preclinical xenograft models.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  324.38

• Molecular Formula:

  C18H20N4O2

• Notes:

  Research use only, not for human use.

• Receptor:

  Wee1

• CAS Number:

  2719793-90-3